Katie Carpenter
Medical · South Charleston, WVNPI 1891108502
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. UCB, Inc. accounts for 65.8% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $9,650, 8.8 times the $1,092 reported in 2021. Among medical clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 561 payments — averaging $46.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$17K
- Johnson & Johnson$2K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Novartis$808
- Lilly USA, LLC$794
- plus $2K from 19 others
What the payments were for
- Consulting fees$7,41428%
- Speaking & faculty fees$7,22028%
- Travel & lodging$1,1925%
- Food & beverage$9,75037%
- Education$5372%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 129 | $17,182 |
| Johnson & Johnson | 103 | $2,030 |
| AbbVie | 102 | $1,798 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,058 |
| Novartis | 28 | $808 |
| Lilly USA, LLC | 41 | $794 |
| Amgen | 12 | $350 |
| Dermavant Sciences, Inc. | 22 | $321 |
| Pfizer | 14 | $305 |
| Boehringer Ingelheim | 13 | $270 |
| Incyte Corporation | 11 | $262 |
| Sun Pharmaceutical Industries Inc. | 7 | $140 |
| E.r. Squibb & Sons, L.L.C. | 6 | $139 |
| Sanofi | 6 | $134 |
| LEO Pharma Inc. | 5 | $103 |
| Galderma Laboratories, L.p. | 5 | $101 |
| Kerecis Limited | 1 | $62 |
| Convatec Inc. | 3 | $61 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Organon | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Biofrontera Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,112 in reported general payments places this provider in the 95th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 28 | $454,664 |
| TremfyaGuselkumab | 24 | $331,566 |
| Dupixent PenDupilumab | 82 | $310,575 |
| Taltz AutoinjectorIxekizumab | 25 | $193,446 |
| OtezlaApremilast | 25 | $106,676 |
| Dupixent SyringeDupilumab | 14 | $49,590 |
| Clobetasol Propionate | 362 | $16,272 |
| Fluorouracil | 173 | $10,799 |
| Triamcinolone Acetonide | 358 | $6,845 |
| Ketoconazole | 215 | $3,498 |
| Doxycycline Hyclate | 200 | $3,193 |
| Tacrolimus | 11 | $2,354 |
| Metronidazole | 46 | $2,312 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 29 | $1,563 |
| Clindamycin Phosphate | 27 | $1,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $2,030 | $331,56624 claims |
| AmgenOtezla | $350 | $106,67625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 medical providers in West Virginia.
Other medical in South Charleston
- Katherine BoggsSouth Charleston$46K
- Kellie HanselSouth Charleston$12K
- Holli CaragSouth Charleston$7K
- Lauren ShafferSouth Charleston$6K
- Timothy DouglasSouth Charleston$6K
- Jacqueline McCartySouth Charleston$5K
- Anthony KnellSouth Charleston$4K
- Kelsey MathisSouth Charleston$3K
- Shelley GaumSouth Charleston$2K
- Lowell LarewMorgantown$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.